160 related articles for article (PubMed ID: 15136164)
1. Cell-based screen of HMG-CoA reductase inhibitors and expression regulators using LC-MS.
Gerber R; Ryan JD; Clark DS
Anal Biochem; 2004 Jun; 329(1):28-34. PubMed ID: 15136164
[TBL] [Abstract][Full Text] [Related]
2. Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies.
Pasha MK; Muzeeb S; Basha SJ; Shashikumar D; Mullangi R; Srinivas NR
Biomed Chromatogr; 2006 Mar; 20(3):282-93. PubMed ID: 16143964
[TBL] [Abstract][Full Text] [Related]
3. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
5. The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase.
Maciejak A; Leszczynska A; Warchol I; Gora M; Kaminska J; Plochocka D; Wysocka-Kapcinska M; Tulacz D; Siedlecka J; Swiezewska E; Sojka M; Danikiewicz W; Odolczyk N; Szkopinska A; Sygitowicz G; Burzynska B
BMC Biotechnol; 2013 Aug; 13():68. PubMed ID: 24128347
[TBL] [Abstract][Full Text] [Related]
6. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
7. Different statins produce highly divergent changes in gene expression profiles of human hepatoma cells: a pilot study.
Leszczynska A; Gora M; Plochocka D; Hoser G; Szkopinska A; Koblowska M; Iwanicka-Nowicka R; Kotlinski M; Rawa K; Kiliszek M; Burzynska B
Acta Biochim Pol; 2011; 58(4):635-9. PubMed ID: 22132374
[TBL] [Abstract][Full Text] [Related]
8. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
Cenedella RJ
Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
Dansette PM; Jaoen M; Pons C
Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography-tandem mass spectrometry method for the measurement of serum mevalonic acid: a novel marker of hydroxymethylglutaryl coenzyme A reductase inhibition by statins.
Waldron J; Webster C
Ann Clin Biochem; 2011 May; 48(Pt 3):223-32. PubMed ID: 21355014
[TBL] [Abstract][Full Text] [Related]
11. Automated enzyme inhibition assay method for the determination of atorvastatin-derived HMG-CoA reductase inhibitors in human plasma using radioactivity detection.
Valesky RJ; Liu L; Musson DG; Zhao JJ
J Pharmacol Toxicol Methods; 2008; 57(1):61-9. PubMed ID: 17651990
[TBL] [Abstract][Full Text] [Related]
12. Comparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition.
Boerma M; Burton GR; Wang J; Fink LM; McGehee RE; Hauer-Jensen M
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):173-80. PubMed ID: 16575254
[TBL] [Abstract][Full Text] [Related]
13. Induction of macrophage elastase (MMP-12) gene expression by statins.
Arikan MC; Shapiro SD; Mariani TJ
J Cell Physiol; 2005 Jul; 204(1):139-45. PubMed ID: 15605420
[TBL] [Abstract][Full Text] [Related]
14. Comparison of UV and charged aerosol detection approach in pharmaceutical analysis of statins.
Nováková L; Lopéz SA; Solichová D; Satínský D; Kulichová B; Horna A; Solich P
Talanta; 2009 May; 78(3):834-9. PubMed ID: 19269437
[TBL] [Abstract][Full Text] [Related]
15. Regulation and degradation of HMGCo-A reductase.
Panda T; Devi VA
Appl Microbiol Biotechnol; 2004 Dec; 66(2):143-52. PubMed ID: 15558272
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the class II HMG-CoA reductase of Pseudomonas mevalonii.
Hedl M; Rodwell VW
Protein Sci; 2004 Jun; 13(6):1693-7. PubMed ID: 15152097
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors.
Kubota T; Fujisaki K; Itoh Y; Yano T; Sendo T; Oishi R
Biochem Pharmacol; 2004 Jun; 67(12):2175-86. PubMed ID: 15163549
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
Chen GP; Yao L; Lu X; Li L; Hu SJ
Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
[TBL] [Abstract][Full Text] [Related]
20. Chromatography-mass spectrometry methods for the quantitation of statins in biological samples.
Nirogi R; Mudigonda K; Kandikere V
J Pharm Biomed Anal; 2007 Jun; 44(2):379-87. PubMed ID: 17433599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
